The testicular-extract injection protocol is safe; the preparation does not produce significant adverse reactions and the procedure presents no meaningful health risk to the recipient.
The safety claim was central to the commercial viability of ‘Brown-Séquard’s elixir’ and the related testicular-extract preparations sold by pharmacists from 1890 onward. The claim was empirically true in the narrow sense that the aqueous extract, containing essentially no biologically active substance, also delivered essentially no biological harm in the short term. It was substantively false on the broader question of sterile preparation and infection risk: nineteenth-century pharmacy practice did not consistently meet modern sterility standards, and crude tissue extracts injected subcutaneously carried infection risk that was not systematically documented. The claim is refuted by modern infectious-disease and pharmacology standards, under which a crude unsterile animal-tissue extract would not be approved for human injection regardless of the active-substance content.
Appears in
Sources
- Brown-Séquard's Elixir — period advertisement — Representative period advertisement for 'Brown-Séquard's Elixir' or related testicular-extract preparations, circa 1890, as appeared in European and North American medical and lay press following Brown-Séquard's 1889 announcement. Specific publication, advertiser, and exact date vary across the extant archival record; representative examples are held in the Wellcome Collection (London) and in the History of Medicine collections of major US medical libraries.